Topics
The Retina Pipeline
Broadening the Scope of Complement Inhibitor Treatment
View Insert
Raising the Bar
Sponsored by BVI
Rising Stars in Retina: Luciano Custo Greig, MD, PHD
Editorially independent supported by Abbvie and Regenxbio
One to Watch: Parisa Emami-Naeini, MD, MPH
Business Matters: Making the Midcareer Move
Editorially independent content supported with advertising by Apellis and Regeneron
View Supplement
Advancing Treatment Strategies for Better Outcomes in Diabetic Eye Disease and nAMD
This activity is supported by an independent educational grant from Regeneron.
Surgical Rounds
One to Watch: Kapil Mishra, MD
Rising Stars in Retina: Ellie Xiao Yi Zhou, MD
Diabetic Eye Disease
One to Watch: Sarwar Zahid, MD
Rising Stars in Retina: Farzad Jamshidi, MD, PhD
Fundamentals of the Diagnosis and Management of Inherited Retinal Diseases
Independent medical education supported by Johnson & Johnson, Neurotech Pharmaceuticals and Alkeus Pharmaceuticals. Content supplied by Euretina.
Business Matters: Building a Private Practice
Rare and Inherited Retinal Diseases
AbbVie: Honoring Its Legacy to Guide Its Future
Sponsored by AbbVie
One to Watch: Narine Viruni, MD
One to Watch: Kenneth C. Fan, MD, MBA
Rising Stars in Retina: Suzie A. Gasparian, MD
Subthreshold Yellow Laser for Recurrent Central Serous Chorioretinopathy
Sponsored by Nidek
Real-World Challenges Managing Retinal Diseases
This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.
The AMD Treatment Landscape
How Do You Engage With Your Referral Network?
Editorially Independent Content, Supported With Advertising From Astellas
One to Watch: Danny A. Mammo, MD
One to Watch: Ashley M. Crane, MD
Rising Stars in Retina: Asad F. Durrani, MD
Elevating the Standard of Care in Wet AMD
Sponsored by Opthea
The Evolving Treatment Paradigm in Geographic Atrophy
Content sponsored by Apellis
Geographic Atrophy: Options in Clinical Therapy
Editorially Independent Content, Supported With Advertising From Astellas and Carl Zeiss Meditec
Business Matters: Patient Care in the Age of Private Equity
Editorially independent content supported with advertising by Regeneron
Maximizing Therapy for Geographic Atrophy
This activity is supported by an unrestricted educational grant from Astellas.
KOL Knockout™ Retina Edition: Experts Face Off on 8 Challenging Cases
This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
The Imaging Issue
Geographic Atrophy: Guiding the Conversation With Patients
Beyond the Scope: Exploring the Augmented Reality Revolution in Ophthalmology
Sponsored by Beyeonics Vision
One to Watch: Frank Brodie, MD, MBA
Rising Stars in Retina: Inês Laíns, MD, PhD
Diversity and Inclusion
One to Watch: Matthew R. Starr, MD
Rising Stars in Retina: Jesse D. Sengillo, MD
Leveraging Siglec Receptors to Repolarize Macrophages for the Treatment of Geographic Atrophy
Supplied and Sponsored by Aviceda Therapeutics
Image of the Year
Connecting Signs and Symptoms and Fostering Collaboration in Symptomatic Vitreous Opacities
Editorially independent content supported by advertising from Alcon and Heidelberg Engineering
Practical Considerations for GA Treatment in the Real World
Independent Medical Education Supported by Apellis, Iveric Bio (an Astellas company) and Zeiss.
Business Matters: Make Way for More Patients
Surgical Techniques and Technologies
Rising Stars in Retina: Leanne M. Clevenger, MD
One to Watch: Sruthi Arepalli, MD
Lasers for Retina
Sponsored by Lumibird Medical
Clinical Benefits of Mirante
Sponsored by NIDEK
Advances in Retinal Disease Therapies
This activity is supported by an unrestricted educational grant from Regeneron.
Elevating nAMD Management Through Advances in Durability
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
